Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Epidemiology

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ije/dyt243PMID 24374889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

  2014cited by this paper
• Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study.

  2011cited by this paper
• Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

  2010cited by this paper
• Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes.

  2010cited by this paper
• Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence

  2010cited by this paper
• HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.

  2010cited by this paper
• Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.

  2010cited by this paper
• HIV/AIDS Behavioral Interventions in China: A Literature Review and Recommendation for Future Research

  2009cited by this paper
• Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.

  2008cited by this paper
• Frequent needle exchange use and HIV incidence in Vancouver, Canada.

  2007cited by this paper
• Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

  2007cited by this paper
• Effectiveness of sterile needle and syringe programmes

  2005cited by this paper
• HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

  2005cited by this paper
• Grading quality of evidence and strength of recommendations

  2004cited by this paper
• Open access publishing takes off

  2004cited by this paper
• Grading quality of evidence and strength of recommendations

  2004cited by this paper
• Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.

  2003cited by this paper
• Criteria for evaluating evidence on public health interventions

  2002cited by this paper
• Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis.

  2001cited by this paper
• Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users.

  2001cited by this paper
• Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.

  2001cited by this paper
• Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health

  2001cited by this paper
• Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.

  2000cited by this paper
• Prevention of HIV Infection in Street‐Recruited Injection Drug Users

  2000cited by this paper
• Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

  1999cited by this paper
• Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.

  1998cited by this paper
• Needle exchange is not enough: lessons from the Vancouver injecting drug use study

  1997cited by this paper
• High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.

  1997cited by this paper
• Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT.

  1997cited by this paper
• Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

  1997cited by this paper
• Determinants of HIV seroconversion in drug users during a period of rising prevalence in Vancouver

  1997cited by this paper
• HIV incidence among injecting drug users in New York City syringe-exchange programmes.

  1996cited by this paper
• Needle exchange use among a cohort of injecting drug users

  1996cited by this paper
• The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.

  1992cited by this paper
• Needle exchange.

  1987cited by this paper

• A comprehensive review of state laws that govern the distribution and possession of drug use equipment in the United States.

  2026cites this paper
• HIV-1 Prevalence and Oral Pre-Exposure Prophylaxis Effectiveness and Prevalence of Use Among Key Populations in High-Income Economies (2017–2023): A Systematic Review and Meta-Analysis of Real-World Studies

  2026cites this paper
• Sociodemographic, behavioral, and geospatial factors associated with syringe services program use in San Francisco, California.

  2026cites this paper
• Changes in Risk Behaviour Among People With Recent Injecting Drug Use in Oslo 2002-2024.

  2025cites this paper
• A qualitative study of health, social, and community professionals’ practices to reduce alcohol-related risks among people living in social precarity in the Greater Paris region

  2025cites this paper
• Navigating the HIV/AIDS epidemic in Bangladesh: A comprehensive retrospective analysis of epidemiological trends and sex-specific disparities (1990–2021) with long-term ARIMA forecasting to 2050 for strategic public health planning

  2025cites this paper
• Evidence for the efficacy of humanizing narratives to promote support for harm-reduction policies in the United States

  2025cites this paper
• “New Normal:” Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 Pandemic

  2025influential citation
• Harm Reduction Strategies for Opioid Use Disorder

  2025cites this paper
• Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya: a latent class analysis signaling needs for innovation in service delivery.

  2025cites this paper
• Perspectives of syringe services program operators in Michigan on their relationship with substance use treatment: a qualitative study

  2025cites this paper
• Integrating harm reduction and addiction care in HIV prevention among persons who inject drugs in the United States—a narrative review

  2025cites this paper
• National trends in co-use of opioids and methamphetamine among people who inject drugs, 2012-2018.

  2025cites this paper
• Linkage to substance use disorder treatment through syringe services programs and the criminal legal system: A Cross-Sectional Study.

  2025cites this paper
• Tribally-affiliated syringe services programs in the United States: a brief report

  2025cites this paper
• Strategies to Achieve HIV and HCV Infection Incidence Targets Among People Who Inject Drugs: A Stochastic Network-Based Multi-Disease Transmission Modeling Study

  2025cites this paper
• Assessing the student pharmacist's comfort level with harm reduction strategies via clinical exposure.

  2025cites this paper
• Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya

  2025cites this paper
• Substance Checking Outreach and PrEP Engagement (SCOPE) Study: protocol for a non-randomised clinical trial in Baltimore, Maryland USA

  2025cites this paper
• Predictors of Awareness of Fentanyl Test Strips Among People Who Inject Drugs in Northeast Georgia

  2025cites this paper
• Preferences for harm reduction vending machine design among rural people who use drugs

  2025cites this paper
• Estimating the Cost-Saving Threshold of a Rural Syringe Services Program Before and During the COVID-19 Pandemic

  2025cites this paper
• Willingness to Take Long-Acting Injectable Preexposure Prophylaxis (PrEP) and Preference for PrEP Modalities Among People Who Inject Drugs in Washington, DC

  2025cites this paper
• HIV Prevention Among People Who Inject Drugs (PWID): A Narrative Review

  2025cites this paper
• Local data for local programming: Results from an HIV biobehavioral survey among people who inject drugs in Livingstone, Lusaka, and Ndola, Zambia, 2021

  2025cites this paper
• HIV vaulnerability among people who inject drugs (PWID): findings from the Bangladesh integrated biological and behavioural surveillance (IBBS) study 2020

  2025cites this paper
• HOME protocol for a national online survey of people who inject drugs

  2025cites this paper
• HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here?

  2025cites this paper
• The Intersection of Substance Use Disorders and Infectious Diseases in the Emergency Department.

  2024cites this paper
• Kentucky Outreach Service Kiosk (KyOSK) Study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural Appalachia

  2024cites this paper
• An evaluation of first responders’ intention to refer to post-overdose services following SHIELD training

  2024cites this paper
• Global Elimination of Hepatitis C Virus.

  2024cites this paper
• Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019

  2024cites this paper
• Correction: Rapid Assessment Amid an Injection Drug Use-Driven HIV Outbreak in Massachusetts’ Merrimack Valley: Highlights from a Case Study

  2024cites this paper
• A hand-washing community-based educational intervention to reduce abscess incidence among people who inject drugs: a cluster randomised controlled clinical trial protocol (the HAWA study protocol)

  2024cites this paper
• A qualitative exploration of harm reduction in practice by street-based peer outreach workers

  2024cites this paper
• From Response to Prevention: Enhancing EMS Impact With Harm Reduction and HIV Education

  2024cites this paper
• Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach

  2024cites this paper
• Community pharmacists’ attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey

  2024cites this paper
• Harm Reduction: The Neglected Pillar of US Drug Policy.

  2024cites this paper
• Past-Year HIV Testing, Current Antiretroviral Therapy Use, and Participation in Services for People Who Inject Drugs

  2024cites this paper
• Disruptions to HIV Prevention During Armed Conflict in Ukraine and Other Settings

  2024cites this paper
• A Whole-Person Approach to Harm Reduction for Women

  2024cites this paper
• Rapid Assessment Amid an Injection Drug Use-Driven HIV Outbreak in Massachusetts’ Merrimack Valley: Highlights from a Case Study

  2024cites this paper
• In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)

  2024cites this paper
• Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists

  2024cites this paper
• Unveiling the dynamics of drug transmission: A fractal-fractional approach integrating criminal law perspectives

  2024cites this paper
• “Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda

  2024cites this paper
• The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.

  2024cites this paper
• Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping

  2024influential citation
• A Qualitative Analysis of Barriers to Accessing HIV Prevention Services During an HIV Outbreak among Persons who Inject Drugs in West Virginia

  2024cites this paper
• Statewide efforts to address the opioid epidemic: Results from a national survey of single state agencies.

  2024cites this paper
• Harm Reduction for Opioid Use Disorder: Strategies and Outcome Metrics.

  2024cites this paper
• Effectively engaging faith-based leaders on syringe services programs: U.S. pastors’ knowledge, perceptions, and questions

  2024cites this paper
• Needle exchange programs and their impact on HIV incidence in West Virginia: Is it working?

  2023cites this paper
• A mixed methods exploration of injection drug use risk behaviors and place-based norms in Ukraine.

  2023cites this paper
• HIV and HCV testing at clinical encounters among people who inject drugs, 2013–2018—Opportunities for increased testing and prevention

  2023cites this paper
• Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis

  2023cites this paper
• HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA

  2023cites this paper
• Global associations of key populations with HIV-1 recombinants: a systematic review, global survey, and individual participant data meta-analysis

  2023cites this paper
• Elucidating Harm Reduction Principles in a Client-Centered Representative Payee Program

  2023cites this paper
• Mortality associated with bacterial and fungal infections and overdose among people with drug use diagnoses.

  2023cites this paper
• 'New evidence' for Syringe Services Programs? A call for rigor and skepticism.

  2023cites this paper
• A Case for Needle Exchange Programs: Not Letting Perfection be the Enemy of the Good

  2023cites this paper
• Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation

  2023cites this paper
• The Impact of Needle and Syringe Exchange Programs on HIV-Related Risk Behaviors in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis Examining Individual- Versus Community-Level Effects

  2023cites this paper
• Rationale, evidence, and steps for implementation of medication for opioid use disorder treatment programs in HIV primary care settings

  2023cites this paper
• Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

  2023cites this paper
• People living with HIV who inject or have injected non-prescription drugs: Evidence of substantial differences in health inequalities and experiences of clinical care.

  2023cites this paper
• Syringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders.

  2023cites this paper
• Are We Witnessing a New Wave of Substance Use Disorders?: A Spotlight on Stimulant Use Disorders.

  2023cites this paper
• Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track?

  2023cites this paper
• A harm reduction journey: Connection, family support, and engagement in health care.

  2023cites this paper
• Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study

  2023cites this paper
• Trends in HIV incidence following scale-up of harm reduction interventions among people who inject drugs in Kachin, Myanmar, 2008–2020: analysis of a retrospective cohort dataset

  2023cites this paper
• The impact of syringe decriminalization within the Pennsylvania harm reduction community.

  2023cites this paper
• Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: a pooled analysis of emulated trials.

  2023cites this paper
• Everything but the Kitchen Sink: An Analysis of Bacterial and Chemical Contaminants Found in Syringe Residue From People Who Inject Drugs

  2023cites this paper
• The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study

  2023cites this paper
• Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-center Observational Study

  2022cites this paper
• Nurses and Outreach Workers’ Stigmatizing Attitudes in Needle Syringe Programs in Kazakhstan

  2022cites this paper
• Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020).

  2022cites this paper
• Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation

  2022cites this paper
• Securing wider EU commitment to the elimination of hepatitis C virus

  2022cites this paper
• Determinants of health among people who use illicit drugs in the conflict-affected countries of Afghanistan, Colombia and Myanmar: a systematic review of epidemiological evidence

  2022cites this paper
• Effect of HCV or HIV infection on mortality among hospitalized persons who used opioids, 2000-2010.

  2022cites this paper
• Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives

  2022cites this paper
• Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada

  2022cites this paper
• Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya

  2022cites this paper
• Use of pre-exposure prophylaxis (PrEP) to prevent rapid HIV transmission among people who inject drugs (PWID) in rural counties in the United States: A modeling study.

  2022cites this paper
• Factors Associated with Exchange Sex Among Cisgender Persons Who Inject Drugs: Women and MSM—23 U.S. Cities, 2018

  2022cites this paper
• Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage

  2022cites this paper
• Editorial on ‘Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: nearly 40 years on’

  2022cites this paper
• Association Between Dual Partnership and Sexual and Injecting Behaviors Among Persons Who Inject Drugs in 23 US Cities, 2018

  2022cites this paper
• Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis

  2022cites this paper
• Effectiveness of Interventions for Prevention of Common Infections Among Opioid Users: A Systematic Review of Systematic Reviews

  2022cites this paper
• Perception of Resource Allocations to Address the Opioid Epidemic

  2022cites this paper
• Modeling the impact of interventions during an outbreak of HIV infection among people who inject drugs in 2012-2013 in Athens, Greece.

  2022influential citation
• Urgent need to expand syringe services programs in South Carolina and beyond

  2022cites this paper
• Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden

  2022cites this paper